600993.SHG Mayinglong Pharmaceutical Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
24.96 CNY
Close of Nov 5, 2026
21.22 30.18
Market cap
CNY 10.8B
P/E
18.1x
P/B
2.38x
ROE
14.9%
Dividend yield
2.51%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600993.SHG undervalued?

Graham number
Price24.96
Graham value18.06
Premium38.2%

600993.SHG trades 38.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mayinglong Pharmaceutical Group Co Ltd fundamental analysis

No fundamental analysis for Mayinglong Pharmaceutical Group Co Ltd yet.

Mayinglong Pharmaceutical Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mayinglong Pharmaceutical Group Co Ltd

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosme…

Full company profile